Article
Frequency of Gγ-globin promoter -158 (C>T) XmnI polymorphism in patients with homozygous/compound heterozygous beta thalassaemia.
Hematology/oncology and stem cell therapy - 1 Mar 2015
Ali Nadir, Ayyub Muhammad, Khan Saleem Ahmed, Ahmed Suhaib, Abbas Kazim, Malik Hamid Saeed, Tashfeen Sunila
Abstract excerpt
BACKGROUND: Response to hydroxyurea therapy in homozygous or compound heterozygous beta thalassaemia (BT) has been reported as more favourable in the presence of XmnI polymorphism. The prevalence of XmnI polymorphism may vary with BT phenotypes and genotypes, and differs geographically in distribution. Prevalence of XmnI polymorphism is not known in northern Pakistan. OBJECTIVE: To determine the frequency of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
